SGRY Insider Trading Activity and SEC Form 4 Filings
SGRY insider trading summary
Over the past 12 months, insiders at Surgery Partners, Inc. (SGRY) reported 12 sales worth $1.3M by 6 insiders and 2 open-market purchases worth $305K by 1 insider on SEC Form 4. Net insider selling was $979K.
Latest SGRY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Teresa DeLuca | Director | Buy | $161K (11,250 @ $14.33) |
| Aug 18, 2026 | Teresa DeLuca | Director | Buy | $144K (10,000 @ $14.35) |
| Mar 16, 2026 | Jason Eric Evans | Chief Executive Officer | Sell | $254K (20,400 @ $12.47) |
| Mar 16, 2026 | David T Doherty | Chief Financial Officer | Sell | $111K (8,867 @ $12.50) |
| Mar 13, 2026 | Danielle Burkhalter | Chief Human Resources Officer | Sell | $45K (3,469 @ $12.83) |
| Mar 13, 2026 | Marissa Brittenham | Chief Strategy Officer | Sell | $46K (3,657 @ $12.54) |
| Mar 12, 2026 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | $76K (5,798 @ $13.17) |
| Mar 6, 2026 | David T Doherty | Chief Financial Officer | Sell | $202K (14,574 @ $13.84) |
| Mar 6, 2026 | Danielle Burkhalter | Chief Human Resources Officer | Sell | $105K (7,736 @ $13.60) |
| Mar 6, 2026 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | $138K (10,082 @ $13.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.